Lapeer · Rochester Hills · Telehealth

Low Libido
in Women
Why Sexual Desire Decreases — and What Can Be Done About It

Low sexual desire is the most common sexual complaint among women — and one of the least addressed in clinical settings. It is not simply a natural consequence of aging, stress, or a long relationship. It has identifiable hormonal, psychological, relational, and medication-related contributors, each of which responds to different management approaches. The starting point is a clinical evaluation that takes the concern seriously and looks for the right causes.

Dr. Ramona D. Andrei, MD, PhD, FACOG evaluates and manages low libido as part of comprehensive sexual health care at both our Lapeer and Rochester Hills offices.

Board-certified gynecology & minimally invasive surgery  ·  Most major insurances accepted
Serving Lapeer County & Oakland County

Low Sexual Desire — Understanding Hypoactive Sexual Desire Disorder

Low libido in women — clinically termed hypoactive sexual desire disorder (HSDD) when it causes personal distress — is the most prevalent female sexual dysfunction and among the most undertreated. Studies suggest that approximately 10 percent of premenopausal women and up to 40 percent of postmenopausal women experience low sexual desire that they find distressing. Yet the majority never discuss it with their healthcare provider.

Female sexual desire is complex. It is not simply a hormonal on/off switch. It involves the interplay of hormonal status, physical health, psychological wellbeing, relationship quality, prior sexual experiences, cultural context, and life circumstances. What this complexity means clinically is that effective management requires identifying which of these contributors is primary for the individual woman — because treating a hormonal contributor with psychotherapy alone, or a psychological contributor with hormones alone, produces incomplete results.

The evaluation at Lapeer Women’s Health assesses the hormonal, physical, and medication-related contributors to low libido that gynecologic evaluation can directly address, while acknowledging the psychological and relational dimensions that may benefit from additional support.

Contributing Causes of Low Libido in Women

Hormonal Changes — Estrogen and Testosterone Deficiency

Estrogen and testosterone both contribute to female sexual desire and response. Estrogen maintains the vaginal and vulvar tissue health that allows comfortable intimacy and supports the vasocongestion response that produces arousal lubrication. When estrogen declines in perimenopause and menopause, the physical discomfort of vaginal dryness and dyspareunia directly reduces desire through the anticipation of pain. Testosterone — produced by the ovaries and adrenal glands — supports sexual motivation, arousal, and response. Ovarian testosterone production declines significantly at menopause and after oophorectomy, producing a reduction in desire that is distinct from the estrogen-mediated physical changes. Both contributors are assessed in the hormonal evaluation at Lapeer Women’s Health.

Antidepressant and Medication Effects

SSRIs and SNRIs — among the most widely prescribed medications in the United States — significantly reduce sexual desire, arousal, and orgasm in a substantial proportion of women who take them. This side effect is frequently not discussed at the time of prescription and is often attributed by women to other causes including their depression or anxiety itself. Antihypertensives, hormonal contraceptives with high progestogenic and antiandrogenic activity, and certain other medications also reduce libido through various mechanisms. A thorough medication review is an essential component of the low libido evaluation.

Chronic Pain and Dyspareunia

When intercourse is painful — from vulvodynia, genitourinary atrophy, endometriosis, or pelvic floor dysfunction — the anticipation of pain predictably reduces desire. This is a physiologically rational response that is often interpreted as a primary desire problem rather than a secondary consequence of physical discomfort. Addressing the pain source typically restores desire to its baseline once the association between intimacy and pain is removed. This is why accurate diagnosis of dyspareunia is the prerequisite for effective libido management in women with pain during sex. Learn about painful sex →

Thyroid Dysfunction and Chronic Conditions

Hypothyroidism produces fatigue, low energy, and mood changes that reduce sexual desire and is a commonly missed contributor to low libido in women. Diabetes, cardiovascular disease, chronic pain conditions, and autoimmune conditions all affect sexual function through hormonal, vascular, and neurologic mechanisms. Thyroid function testing is a standard component of the low libido evaluation when hypothyroidism has not been recently excluded.

Psychological and Relational Contributors

Depression and anxiety are among the most significant psychological contributors to low libido — independent of the medications used to treat them. Relationship conflict, communication difficulties, loss of attraction, history of sexual trauma, body image concerns, and significant life stressors all affect desire in ways that are not primarily hormonal. When psychological or relational contributors are primary, coordination with a therapist or sexual health specialist produces better outcomes than gynecologic intervention alone. Dr. Andrei identifies the psychological and relational dimensions that warrant additional support and coordinates referrals when indicated.

When Low Libido Warrants Prompt Evaluation

Low libido is almost always addressed through a scheduled evaluation. Contact our office promptly if reduced desire is accompanied by:

  • Symptoms suggesting premature ovarian insufficiency before age 40 — including irregular periods, hot flashes, and low desire in combination
  • Significant unexplained fatigue, weight gain, or cold intolerance suggesting untreated hypothyroidism
Lapeer: (810) 969-4670  ·  Rochester Hills: (248) 923-3522
Low Libido Evaluation and Management at Lapeer Women’s Health

Comprehensive History and Medication Review

The evaluation reviews the timeline of desire changes relative to hormonal events (perimenopause, menopause, oophorectomy, starting a new medication), current medications and their potential sexual side effects, thyroid and metabolic health, pain with intercourse, and the psychological and relational context. This comprehensive history identifies the most likely primary contributors before testing and examination.

Hormonal and Laboratory Testing

Estradiol, total and free testosterone, DHEA-S, thyroid function, and other markers when clinically indicated are assessed. Examination evaluates vaginal and vulvar tissue health, genitourinary atrophy, and pelvic floor tone. The combination of laboratory data and examination findings identifies the hormonal and physical contributors that are amenable to clinical intervention.

Individualized Management

Local or systemic estrogen for atrophy and genitourinary causes. Low-dose testosterone therapy for androgen deficiency in appropriate candidates. Medication review and adjustment when SSRIs or other medications are contributing. Treatment of dyspareunia when pain is driving desire reduction. Referral to sexual health specialists or mental health providers when psychological or relational contributors are primary.

Low Libido That Is Affecting Your Relationship or Quality of Life Deserves a Clinical Evaluation

Many women accept reduced sexual desire as something they simply have to live with — because it feels too personal to raise with a doctor, because they assume nothing can be done, or because prior attempts to discuss it were met with inadequate time or dismissiveness. Low libido that is causing personal distress or relationship difficulty is a legitimate clinical concern with identifiable causes and effective management options.

Dr. Ramona D. Andrei and the team at Lapeer Women’s Health are here to have that conversation — at both our Lapeer and Rochester Hills offices, without a referral required.

Frequently Asked Questions About
Low Libido in Women
It is often both — and the distinction matters for management. Low libido with a primary hormonal or medication cause is a medical condition that responds to medical intervention. Low libido driven primarily by relationship conflict, communication breakdown, or psychological factors is a relational or psychological concern that responds to therapy and counseling. Many women have both contributing simultaneously — and addressing only one produces incomplete improvement. The clinical evaluation at Lapeer Women’s Health identifies the physiologic contributors; the full picture includes acknowledgment of the relational and psychological dimensions that may warrant additional support alongside medical management.
Evidence supports the use of low-dose testosterone therapy for improving sexual desire in postmenopausal women with hypoactive sexual desire disorder, with multiple randomized trials demonstrating meaningful improvement in desire, arousal, and sexual satisfaction. There are no FDA-approved testosterone products specifically formulated for women in the United States, so treatment uses compounded low-dose preparations at doses appropriate for female physiology — far lower than male doses. Dr. Andrei discusses testosterone therapy as an option for appropriate candidates as part of the hormonal management conversation, including the evidence base, the practical considerations of compounded preparations, and the monitoring required during treatment.
Several options exist and are worth discussing with both your prescribing clinician and your gynecologist. Adding low-dose bupropion alongside the SSRI has evidence for improving SSRI-related sexual dysfunction. Switching to bupropion or mirtazapine as the primary antidepressant is appropriate for some patients and may restore sexual function while maintaining antidepressant efficacy. Dose reduction if clinically appropriate may reduce sexual side effects. These decisions require coordination with the prescribing provider. The gynecologic contribution at Lapeer Women’s Health is identifying that the medication is a significant contributor and providing a clinical framework for the conversation with the prescriber.
Yes. Low libido evaluations are available at both the Lapeer office (1245 N Main St, Lapeer, MI — (810) 969-4670) and the Rochester Hills office (2710 S Rochester Rd, Suite 2, Rochester Hills, MI — (248) 923-3522). No referral is required to schedule.
Board-certified gynecology & minimally invasive surgery  ·  Most major insurances accepted  ·  Convenient locations in Lapeer & Rochester Hills
Low Libido Has Identifiable Causes. Let’s Find Yours.

Our team at Lapeer Women’s Health evaluates the hormonal and physical contributors to low libido at both our Lapeer and Rochester Hills offices. No referral required.

Schedule a Gynecologic Visit

Educational purposes only. Not medical advice. Content reviewed by Dr. Ramona D. Andrei, MD PhD FACOG.

Gynecologic care for women of every age

Lapeer Women’s Health — Rochester Hills
2710 S Rochester Rd, Suite 2
Rochester Hills, MI 48307

Serving patients in Lapeer, Rochester Hills, and surrounding communities throughout Southeast Michigan.